Atea Pharmaceuticals (AVIR) Stock Chart & Stock Price History $2.90 +0.02 (+0.69%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$2.90 0.00 (0.00%) As of 04/3/2025 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Atea Pharmaceuticals Stock Price Performance 5 Day Performance-1.02%1 Month Performance0.00%3 Month Performance-17.61%6 Month Performance-12.91%Year-To-Date Performance-13.43%1 Year Performance-25.64% Receive AVIR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address AVIR Stock Chart for Friday, April, 4, 2025 AVIR Chart by TradingViewRemove Ads Atea Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/03/2025$2.88$2.90+0.69%$3.01$2.76282,037 shs$248.02 million04/02/2025$2.85$2.88+1.05%$2.92$2.77245,113 shs$246.31 million04/01/2025$2.99$2.85-4.68%$2.98$2.81347,976 shs$243.75 million03/31/2025$2.93$2.99+2.05%$3.03$2.92240,650 shs$255.72 million03/28/2025$3.02$2.93-2.98%$3.04$2.90217,565 shs$250.59 million03/27/2025$3.18$3.02-5.03%$3.14$3.00184,720 shs$258.29 million03/26/2025$3.20$3.18-0.63%$3.22$3.14418,982 shs$271.97 million03/25/2025$3.20$3.20$3.22$3.13258,979 shs$273.68 million03/24/2025$3.22$3.20-0.62%$3.29$3.18154,632 shs$273.68 million03/21/2025$3.15$3.22+2.22%$3.29$3.08557,682 shs$275.39 million Get the Latest News and Ratings for AVIR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 03/20/2025$3.17$3.15-0.63%$3.21$3.13124,614 shs$269.40 million03/19/2025$3.17$3.17$3.20$3.13163,630 shs$271.11 million03/18/2025$3.13$3.17+1.28%$3.18$3.05203,034 shs$271.11 million03/17/2025$3.08$3.13+1.62%$3.15$3.04222,480 shs$267.69 million03/14/2025$3.06$3.08+0.65%$3.11$3.06172,232 shs$260.15 million03/13/2025$3.10$3.06-1.29%$3.21$3.03193,371 shs$258.46 million03/12/2025$2.92$3.10+6.16%$3.14$2.90332,914 shs$261.84 million03/11/2025$2.92$2.92$2.92$2.82343,452 shs$246.63 million03/10/2025$2.99$2.92-2.34%$3.02$2.88293,717 shs$246.63 million03/07/2025$3.00$2.99-0.33%$3.05$2.89374,547 shs$252.54 million03/06/2025$3.01$3.00-0.33%$3.05$2.94307,043 shs$253.39 million03/05/2025$2.90$3.01+3.79%$3.03$2.92176,881 shs$254.23 million03/04/2025$2.90$2.90$3.02$2.88517,918 shs$244.94 million03/03/2025$3.03$2.90-4.29%$3.06$2.88270,504 shs$244.94 million Related Companies Qilian International Holding Group Stock Price Chart Mineralys Therapeutics Stock Price Chart Nurix Therapeutics Stock Price Chart Vir Biotechnology Stock Price Chart Intellia Therapeutics Stock Price Chart Collegium Pharmaceutical Stock Price Chart Arcus Biosciences Stock Price Chart Rocket Pharmaceuticals Stock Price Chart Xencor Stock Price Chart Zymeworks Stock Price Chart Receive AVIR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVIR) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atea Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atea Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
